While GLP-1s focus on blood sugar and hunger signals, Cagrilintide enhances the sensation of fullness and slows gastric emptying even further
This article is part of the PlexusDx Education Hub science-backed guidance on GLP-1 medications, metabolic health, and precision weight management
Legal Status Cagrilintide is still in the clinical trial stage and is not yet available as a prescription therapy
Many injuries heal but leave behind tissue that functions poorly
however, human studies are lacking thus far (Mendieta et al., 2016)
Unlike enrolling in a formal clinical trial (which has extensive consent forms explaining experimental status), patients at wellness clinics might assume if a doctor offered it, it must be safe or allowed. Such misunderstandings could lead to feelings of betrayal and litigation if things go wrong